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Critical Role of the TIE2 Endothelial Cell Receptor
in the Development of Definitive Hematopoiesis
definitive hematopoietic activity has been identified (Med-
vinsky et al., 1993). The mesodermally derived region of
the mouse embryo contains a para-aortic splanch-
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1996). In contrast, recent studies have shown that theJapan
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to definitive hematopoiesis when conditioned newbornSunnybrook and Women's College
mice are used in place of irradiated adult mice as recipi-Health Sciences Centre
ents for hematopoietic transplantation (Yoder et al.,2075 Bayview Avenue
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The development of hematopoiesis is closely relatedCanada M4N 3M5
to that of angiogenesis, indicating the existence of³Regeneron Pharmaceuticals, Incorporated
common progenitors, hemangioblasts (Eichmann et al.,777 Old Saw Mill River Road
1997), which are able to differentiate into both HSCsTarrytown, New York 10591
and endothelial cells. Endothelial cells have been sug-
gested to be critical for hematopoiesis, since mice lack-
ing the receptor tyrosine kinases, Flk-1 and Flt-1, die of
Summary defects of endothelial and hematopoietic cell function
(Fong, 1995; Shalaby et al., 1995). Furthermore, Flk-1
We have investigated the function of TIE2/TEK recep- is now suggested to be essential for both endothelial
tor tyrosine kinase in the development of definitive cell and HSC development. Another family of vascular
hematopoiesis. In the vitelline artery at 9.5 days post- endothelial cell receptor tyrosine kinases, TIE1/TIE and
coitum (d.p.c.), TIE21 hematopoietic cells aggregated TIE2/TEK, have also been isolated and characterized
and adhered to TIE21 endothelial cells. Soluble TIE2- (Dumont et al., 1992; Partanen et al., 1992; Iwama et al.,
Fc chimeric protein inhibited the development of 1993). These two receptor tyrosine kinases share unique
hematopoiesis and angiogenesis in the para-aortic structural properties: two immunoglobulin-like domains,
splanchnopleural mesoderm (P-Sp) explant culture, three epidermal growth factor (EGF)-like domains, and
three fibronectin type III-like repeats in the extracellularand TIE2-deficient mice showed severely impaired de-
region and a split catalytic domain in the cytoplasmicfinitive hematopoiesis. An in vitro study revealed that
region. Embryos deficient in TIE1 failed to establishAngiopoietin-1 but not Angiopoietin-2 promoted the
structural integrity of vascular endothelial cells, resultingadhesion to fibronectin (FN) through integrins in TIE2-
in edema and, subsequently, localized hemorrhage (Puritransfected cells and primary TIE21 cells sorted from
et al., 1995; Sato et al., 1995). TIE2-deficient mice show9.5 d.p.c. P-Sp. Adhesion of TIE21 cells induced by
abnormal vascular network formation (Dumont et al.,Angiopoietin-1 enhanced the proliferation of hemato-
1994; Sato et al., 1995). Moreover, an activating mutationpoietic progenitor cells.
in TIE2 causes vascular dysmorphogenesis in humans
(Vikkula et al., 1996).Introduction
Recently, a ligand for the TIE2 receptor, termed Angio-
poietin-1, has been identified by a secretion-trap ex-During mouse embryogenesis, hematopoiesis begins in
pression cloning strategy (Davis et al., 1996). The nucle-the yolk sac at 7.5 days postcoitum (d.p.c.); subse-
otide sequence of Angiopoietin-1 cDNA contains anquently, it shifts to the fetal liver and then to the spleen
open reading frame encoding 498 amino acids includingand bone marrow (Johnson and Moore, 1975). Hemato-
a coiled-coil domain and a fibrinogen-like domain. Al-
poiesis prior to the formation of the fetal liver is known
though Angiopoietin-1 does not affect endothelial cell
as primitive hematopoiesis and is distinguished from growth in culture, mice lacking Angiopoietin-1 display
the adult-type definitive hematopoiesis by its specific angiogenic deficits similar to but slightly less severe
expression of embryonic-type globin in nucleated eryth- than those of mice lacking TIE2 (Suri et al., 1996). This
rocytes. Although committed hematopoietic progenitors finding supports the putative roles for TIE2 and Angio-
can be detected in the yolk sac as early as 7.5±8.5 d.p.c., poietin-1 in angiogenesis. Angiopoietin-2 has been re-
the colony forming cells in spleen (CFU-S) and long- ported to act as a natural antagonist for Angiopoietin-1,
term repopulating hematopoietic stem cells (LTR-HSCs) since it decreased the phosphorylation induced by Angi-
are absent before the circulation is established. In the opoietin-1, suggesting the presence of an elaborate reg-
mouse embryo, a pre-liver intraembryonic site of potent ulation of the TIE2/ligand signaling pathway (Maison-
pierre et al., 1997). TIE2 controls the ability of endothelial
cells to recruit peri-endothelial supporting cells to stabi-§ To whom correspondence should be addressed (e-mail: sudato@
gpo.kumamoto-u.ac.jp). lize the structure of blood vessels and modulate their
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Figure 1. Localization of TIE21 Cells during Early Embryogenesis
(A) Whole-mount embryo of the 9-somite stage (8.5 d.p.c.) stained with anti-TIE2 MAb, TEK4. Anterior-posterior view (Aa), posterior-anterior
view (Ab), and right-left view (Ac). The aggregations composed of TIE21 hematopoietic cells were not detected in 8.5 d.p.c. embryo. Only
presumptive dorsal aorta (p-DA) and yolk sac (ys) stained positively (Figure 1A). Abbreviations: al, allantois; ng, neural groove; ps, primitive
streak.
(B) Whole-mount (Ba, Bc, and Be) and tissue sections (Bb, Bd, and Bf) of a 20-somite (9.5 d.p.c.) embryo stained with anti-TIE2 MAb; TEK4
(Ba and Bb), anti-c-Kit MAb; ACK2 (Bc and Bd), and anti-Flk-1 MAb; AVAS12 (Be and Bf). TIE21 endothelial cells and TIE21 hematopoietic
cell-aggregates in the omphalomesenteric artery (OA) and vitelline artery (VA) were found (Ba). TIE21 cells aggregated and adhered to TIE21
endothelial cells (Bb). c-Kit1 cells located in the OA and VA are shown by arrows (Bc). In (Bd), c-Kit1 cells can be seen aggregating and
adhering to endothelial cells in the OA and VA. Flk-1 expression was mainly observed in endothelial cells (Be); however, in OA and VA, round
cell population adhering to endothelial cells also express Flk-1 (Bf). Scale bar, 20 mm.
function. However, the precise effects of Angiopoietins 1Ba and 1Bb). In this paper, we distinguish the intraem-
bryonic part as OA and the extra-embryonic part as VA.on cells expressing TIE2 have not been elucidated.
In this study, we analyzed the localization of TIE2 pro- TIE21 hematopoietic cells aggregated and adhered to
the endothelial cells expressing TIE2. The immunohisto-tein in murine embryos at 8±9 d.p.c. when the basic
vascular pattern is established and intraembryonic he- chemistry staining using ACK2 showed that c-Kit1 he-
matopoietic cell aggregates also adhered to endothelialmatopoiesis begins. We found a novel function of TIE2-
mediated signaling for the development of definitive he- cells in these arteries (Figures 1Bc and 1Bd). The immu-
nohistochemistry staining using AVAS12 showed thematopoiesis.
vascular endothelial cells and hematopoietic cells were
positive for Flk-1. Flk-1 was extensively expressed onResults
vascular endothelial cells, while TIE2 expression was
rather limited to peripheral regions of a vasculature atLocalization of TIE21 Hematopoietic Cells
during Early Embryogenesis 9.5 d.p.c. (Figures 1Be and 1Bf).
We first examined the expression of TIE2, c-Kit, and
Flk-1 by immunohistochemical analysis of whole-mount Definitive Hematopoietic Differentiation of
TIE21c-Kit1 Cells in OA and VA Regionsand tissue sections of murine embryos using mono-
clonal antibodies (MAbs) against murine TIE2 (TEK4), c- FACS analysis with dual staining revealed that 2.0% of
cells disaggregated from the 9.5 d.p.c. OA and VA cellsKit (ACK2), and Flk-1 (AVAS12) (Figure 1). The aggrega-
tions composed of TIE21 hematopoietic cells were not were TIE21c-Kit1 (Figure 2A). Thus, induction of TIE21c-
Kit1 hematopoietic cells was suggested to occur in thedetected in 8.5 d.p.c. embryos. Only the presumptive
dorsal aorta and yolk sac stained positively (Figure 1A). period from 8.5 d.p.c. to 9.5 d.p.c. Limiting dilution of
TIE21c-Kit1 cells cultured in the presence of OP9 stro-In 9.5 d.p.c. embryos, TIE2 expression was detected in
round hematopoietic cells as well as bipolar endothelial mal cells with a mixture of growth factors, interleukin
(IL)-6, IL-7, stem cell factor (SCF), and erythropoietincells. Although the TIE21 cells were present in the P-Sp
region, many TIE21 cells were also detected in ompha- (Epo) revealed that the frequency of hematopoietic pre-
cursor cells was 83% (1/1.2) (Figure 2C). When singlelomesenteric artery (OA) and vitelline artery (VA) (Figures
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Figure 2. Definitive Hematopoietic Differen-
tiation of TIE21c-Kit1 Cells in the 9.5 d.p.c.
OA and VA
(A) The cells disaggregated from the 9.5 d.p.c.
OA and VA were stained with anti-c-Kit
(ACK2) and anti-TIE2 (TEK4) MAb and then
fractionated by FACS. Sorting gate is indi-
cated by the box. The percentage in each
quadrant indicated is representative of tripli-
cate experiments.
(B) Characterization of recovered hematopoi-
etic cells from single TIE21c-Kit1 cells cul-
tured on OP9 cells. After 14 days of culture,
the phenotypes of recovered cells were ana-
lyzed by flow-cytometry. (Ba) and (Bb) are
derived from an individual clone.
(C) Limiting dilution analysis of the TIE21c-
Kit1 cells. The frequency of colony forming
progenitors was 1/1.2 according to the Pois-
son analysis.
(D) Cells cultured as described in (B) on the
fourteenth day (Da and Dc) and yolk sac
blood cells on 9.5 d.p.c. as a positive control (Db and Dd) were stained with antiembryonic hemoglobin polyclonal antibody (poAb) or antiadult
hemoglobin poAb (Dc and Dd), respectively. Hemoglobin expression is visualized as a red reaction product. Nucleus was counterstained with
hematoxylin. Scale bar, 25 mm.
TIE21c-Kit1 cells were plated on OP9 with four factors explant (Figure 3D). Limiting dilution of cultured TIE21c-
Kit1 cells revealed that 67% (1/1.5) of cells were hemato-described above for 14 days, they showed myeloid, ery-
throid, and B-lymphoid differentiations in vitro, although poietic progenitors (Figure 3E). Moreover, continuous
culture of the explant on OP9 cells promoted the prolifer-the lineage differentiation was different from clone to
clone (Figure 2B). Cultured erythroid cells derived from ation and differentiation of HSCs into various hemato-
poietic cell lineages, such as Mac-1-, B220-, TER119-,TIE21c-Kit1 cells in the 9.5 d.p.c. P-Sp were positive for
adult hemoglobin but negative for embryonic hemoglo- and CD3-positive, but CD4- and CD8-negative cells
(data not shown). It is suggested that multipotential he-bin, while yolk sac erythroid cells reacted with adult
and embryonic hemoglobin (Figure 2D). These results matopoietic stem cells were included in the TIE21c-Kit1
fraction. Taken together, these results demonstrate thatsuggest that erythroid cells derived from P-Sp are of
definitive type. this culture system is able to support definitive hemato-
poiesis and angio-vasculogenesis from P-Sp explant.
Coculture of Para-Aortic Splanchnopleural
Mesoderm Explant The Function of TIE2 in the Development
of Vascular Networks and InductionSince TIE21c-Kit1 cells were not detected in the OA and
VA at 8.5±9.0 d.p.c. (10±13 somite stage), we examined of Hematopoietic Stem Cells
We evaluated the TIE2 function using this coculture sys-the capacity of differentiation and proliferation in the
P-Sp region containing the OA and VA in an in vitro tem. We first prepared chimeric protein having the extra-
cellular domain of TIE2 containing a ligand binding siteculture. Then, we established a coculture system that
supports the growth of both hematopoietic and endo- and human IgG Fc portion (TIE2-Fc) to prevent free li-
gands for TIE2 from binding the native receptors onthelial cells. As shown schematically in Figure 3A, the
P-Sp explant containing a part of the OA of 8.5±9.0 d.p.c. HSCs and endothelial cells. Addition of 10±50 mg/ml
TIE2-Fc suppressed the formation of vascular networks,embryos was cultured on OP9 stromal cells in a mixture
of the different growth factors IL-6, IL-7, SCF, and Epo. especially the fine pattern of branching, while vascular
bed formation was not affected (Figure 4A). As a control,In OP9 stromal cells, only mRNA of TIE2 ligand, Angio-
poietin-1 was detected among angiogenic factors, while CD4-Fc was added in place of TIE2-Fc and had no effect.
Endothelial cells receiving TIE2-Fc were smaller in sizethe transcripts of VEGF, Angiopoietin-1, and Angiopoie-
tin-2 were detected in the 8.5 d.p.c. P-Sp, as in the adult than those of the control (CD4-Fc). Moreover, hemato-
poietic progenitor development was also suppressedovary (Figure 3B).
After 7±14 days, endothelial cells migrated on OP9 dose dependently in the presence of TIE2-Fc (Figure
4B). On the other hand, addition of Flk-1-Fc abolishedcells and formed a vascular structure expressing TIE2
and PECAM-1/CD31 (Figures 3Cb and 3Cc). c-Kit1 and the development of endothelial cells and hematopoietic
cells (Figures 4A and 4B).TIE21 hematopoietic cells also proliferated on the vas-
cular bed (Figure 3Ca and 3Cb) and subsequently dis- TIE2-deficient embryos at 9.5 d.p.c. before showing
lethal bleeding were quite pale compared with wild-typepersed through PECAM-11 endothelial cells (Figure 3Bc)
on OP9 cells. Consistent with the immunohistochemis- embryos, indicating severe anemia. Hematopoiesis in
the TIE2-deficient embryos was analyzed by immuno-try, flow cytometric analysis revealed a small population
of TIE21c-Kit1 cells in the culture of 8.5 d.p.c. P-Sp histochemical staining and an in vitro culture method.
Immunity
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Figure 3. Development of Hematopoietic Cells and Formation of Vascular Networks in the Culture of Para-Aortic Splanchnopleural Mesoderm
(A) Scheme of the in vitro culture system. We explanted 8.5±9.0 d.p.c. tissue (P-Sp explant containing a part of the OA) from C57BL/6 murine
embryos on OP9 stromal cells in 10% FCS containing RPMI1640 medium supplemented with IL-6, IL-7, SCF, and Epo for 7±14 days. From
the explant, endothelial cells proliferated and migrated on OP9 cells and formed vascular beds (vb) after 7 days of culturing. Subsequently,
endothelial cells sprouted on OP9 cells to form a vascular network (vn) after 14 days of culturing. Hematopoietic cells on vascular beds were
remarkably increased in number after 7 days of culturing.
(B) Production of angiogenic cytokines from OP9 and P-Sp. VEGF, Angiopoietin-1 and 22 expression were analyzed by RT-PCR. mRNA of
ovaries from 8-week-old mice was used as a positive control.
(C) Staining profile of the cultured P-Sp explant. Plates were fixed after 7 days of culturing and then stained with anti-c-Kit MAb (Ca) or anti-
TIE2 MAb (Cb). c-Kit and TIE2 expressions were visualized as a red and darkblue reaction product, respectively. Plates were fixed after 14
days of culturing and then stained with anti-PECAM/CD31 MAb (Cc). PECAM-1 expression was visualized as a dark blue reaction product.
Scale bar, 50 mm (Ca and Cb), 100 mm (Cc).
(D) The cells disaggregated from the culture of P-Sp on OP9 stroma cells after 14 days were stained with anti-c-Kit MAb, ACK2 and anti-TIE2
MAb, TEK4, and then fractionated by the FACS. Sorting gate is indicated by the box. The percentage in each quadrant is representative of
triplicate experiments.
(E) Limiting dilution analysis of TIE21c-Kit1 cells from in vitro culture of P-Sp. The frequency of colony forming progenitors was 1/1.5 according
to the Poisson analysis.
The TIE2-deficient embryos lacked the c-Kit1 cells in the biological function of Angiopoietin-1 and -2 in hema-
topoietic cells, we generated a murine pro-B cell line,VA, while aggregations of these cells were detected in
wild-type littermates (Figures 5A and 5B). No hematopoi- Ba/F3 transduced with full-length murine TIE2 (BaF/
TIE2). Cell adhesion to FN was promoted by Angiopoie-etic cells other than mast cells grew from P-Sp explants
of the TIE2-deficient embryos at 8.5 d.p.c., after cocul- tin-1 and cell±cell aggregation was induced by Angio-
poietin-2 (Figure 6A). Ba/F3 cells transfected with anturing with OP9 cells, while lymphomyeloid cells devel-
oped from explants of a wild-type (Figures 5C and 5D). empty vector did not show the change by the addition
of Angiopoietins. The adhesion to FN was promotedThe branching of vascular networks did not develop
well in the P-Sp of the TIE2-deficient embryos on OP9; by the addition of Angiopoietin-1 in a dose-dependent
manner, was completely blocked by the addition of TIE2-however, vascular beds were formed (Figures 5E and 5F).
Fc, and was unaffected by addition of CD4-Fc. Mono-
clonal antibody against b1 integrin inhibited the Angio-Adhesion of the TIE2-Expressing Hematopoietic
Cell Line, BaF/TIE2 to FN poietin-1-mediated adhesion to FN, while IgG had no
effect (Figure 6B). However, this inhibition did not reachThe results mentioned above suggest that TIE2 is re-
quired for the development and proliferation of HSCs basal level. Integrin GRGDS peptide completely sup-
pressed Angiopoietin-1-mediated adhesion to FN butas well as the formation of vascular networks. To clarify
Role of TIE2 in Definitive Hematopoiesis
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Figure 5. Suppression of HSC Development and Vascular Networks
in TIE2-Deficient Embryo
Aggregation of c-Kit1 cells was detected in the VA of wild-typeFigure 4. Function of TIE2 in the Vascular Network and HSC Devel-
(WT) (A) but not in TIE2-deficient embryo at 9.5 d.p.c. (B). In vitroopment
hematopoiesis and the formation of vascular networks were exam-Chimeric protein of extracellular domain of TIE2 and the Fc of human
ined. P-Sp explants were derived from 8.5 d.p.c. WT littermate (CIg (TIE2-Fc) was added in the culture of P-Sp explants, and the
and E) and TIE22/2 embryo (D and F) and cultured on OP9 cells.formation of vascular network (A) and HSC development (B) were
May-GruÈ nwald Giemsa staining showed that a variety of hematopoi-analyzed. (A) After 14 days of culturing, the cells on OP9 cells were
etic cells, including erythroblasts, lymphoid cells, and mature neu-stained with anti-PECAM-1 antibody. There were fine networks of
trophils, were generated after 14 days of culturing of explant fromPECAM-11 endothelial cells in the presence of CD4-Fc (Aa), and no
the WT embryo (C), but only mast cells were generated from thePECAM-11 cells in the presence of Flk-1-Fc (Ab). The formation of
TIE22/2 embryo (D). Vascular networks composed of PECAM-11 cellvascular networks was suppressed in the presence of 10 mg/ml (Ac)
developed successfully in the culture of WT explants (E), while onlyand 50 mg/ml (Ad) of TIE2-Fc. The arrow in (Ac) indicates the small
vascular beds without sprouting were generated from the TIE22/2vascular network. Scale bar, 100 mm. (B) After 14 days of culturing,
embryo (F). Scale bars, 10 mm (A±D), 50 mm (E and F).cells on OP9 cells were harvested and adherent cells were excluded
by G10 column chromatography and then hematopoietic cells were
transferred to methylcellulose containing IL-3, SCF and Epo. Non-
erythroid colonies (open) and colonies containing definitive erythro- efficiently by the addition of Angiopoietin-1 in a dose-
cytes (solid) were counted. Error bars indicate standard error of the
dependent manner. This adhesion was blocked bymean (n 5 5).
GRGDS peptide and TIE2-Fc but not by GRGES (Figure
7B). Angiopoietin-2 did not promote primary TIE21 cells
to adhere to FN. Rather, Angiopoietin-2 suppressed the
GRGES did not (Figure 6B). Thus, adhesion to FN may
cell adhesion induced by Angiopoietin-1 (Figure 7B).
be mediated by integrin through GRGDS on FN. Angio-
To know the effect of cell adhesion induced by Angio-
poietin-2 suppressed the cell adhesion induced by Angi-
poietins on the hematopoiesis, TIE21c-Kit1 cells were
opoietin-1 (Figure 6B).
cultured on FN-coated or noncoated plates in the pres-
ence of Angipoietins and/or SCF. As shown in Figure
7C, Angiopoietin-1 and SCF induced the cell adhesionEffects of Angiopoietins on Primary TIE21 Cells
and proliferation, compared with SCF alone. Addition ofBased on this biological effect of Angiopoietin-1 on
Angiopoietin-2 suppressed the cell adhesion to FN andTIE2-transfected cells, we examined whether primary
cell growth. Hematopoietic cells and colony formingTIE21 cells are promoted to adhere to FN by Angiopoie-
cells grown in each dish were examined (Table 1). It istin-1. As shown in Figure 7A, the TIE21 population (1.8%
evident that Angiopoietin-1 enhanced the proliferationof total cells) was sorted from 9.5 d.p.c. P-Sp and a part
of the OA and VA. Primary TIE21 cells adhered to FN of hemopoietic progenitor cells synergistically with SCF
Immunity
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Figure 6. The Effects of Angiopoietin-1 and
-2 on the TIE2-Transfected Hematopoietic
Cell Line
(A) BaF/TIE2 cells tightly adhered to fibro-
nectin (FN)-coated plates and developed
pseudopods (arrows) on the addition of
Angiopoietin-1 (Ab), unlike control (Aa). Cell
aggregation was induced by the addition of
Angiopoietin-2 (Ac). Scale bar, 25 mm.
(B) The adhesion to FN of BaF/TIE2 cells was
promoted by Angiopoietin-1 in a dose-
dependent manner and completely blocked
by saturation of ligand with TIE2-Fc protein.
This adhesion to FN was suppressed com-
pletely by GRGDS peptide but not by GRGES.
And it was partially suppressed by anti-b1
integrin blocking antibody (KM16) but not by
isotype-matched control IgG. Angiopoietin-2
inhibited this adhesion as a dose-dependent
manner. Error bars indicate standard error of
the mean (n 5 3).
on the FN-coated plates. This effect was not observed the function of TIE2 in the development of hematopoietic
and endothelial cells from P-Sp cells in the presence ofon the noncoated plates.
OP9 and hemopoietic growth factors. As angiogenic
factors, VEGF, Angiopoietin-1, and Angiopoietin-2 wereDiscussion
detected in E8.5 P-Sp, but only Angiopoiein-1 was de-
tected in OP9 cells. We show that TIE21c-Kit1 cells wereIn this report, we emphasize three points. First, we dem-
onstrate the existence of HSCs expressing TIE2 in the generated from the P-Sp explant at 8.5 d.p.c. and that
67% of these were hematopoietic progeitor cells. It isOA and VA regions. OA is formed by the aggregation of
splanchnic mesodermal cells into angiogenic clusters reported that the 10 d.p.c. cultured AGM has the capac-
ity for reconstituting hematopoiesis in vivo (Medvinskyat the posterior region of the embryo at 8.0 d.p.c. This
artery, the continuation of the dorsal aorta, migrates to and Dzierzak, 1996). Consistently, we observed that the
number of TIE21c-Kit1 cells increased rapidly in thethe yolk sac, where it forms a vasculature becoming VA
by 9.0 d.p.c. TIE21c-Kit1 cells were detected in the OA AGM region from 9.5 d.p.c. to 10.5 d.p.c. Endothelial
cells also developed from P-Sp explant at 8.5 d.p.c., andand VA regions at 9.5 d.p.c. We have shown that 83%
of these were hematopoietic progenitor cells that were they were TIE2- and PECAM-1-positive. They formed
vascular beds and networks. Vascular beds are com-able to differentiate into multilineage pathway. Myeloid
cells containing definitive erythroid cells and B cells posed of a dense sheet of endothelial cells, which is
formed by the proliferation of endothelial precursorwere derived from TIE21c-Kit1 cells. TIE21c-Kit1 cells
localized in a line on OA and VA arteries, and this line cells. Vascular networks are formed by branching or
sprouting of endothelial cells. TIE21 and/or c-Kit1 hema-may constitute a migration pathway of HSCs between
P-Sp and yolk sac. Our results suggest that the OA and topoietic cells were observed in the vascular bed at
earlier stage of the culture. Proliferation of endothelialVA are sites for HSC proliferation. The expression of TIE2
and of c-Kit is quite similar to that of CD34 examined by precursor cells or angioblasts may associate with HSC
development.in situ hybridization (Wood et al., 1997). In the OA and VA,
TIE2 plays a critical role in the adhesion of hematopoietic Soluble TIE2-Fc chimeric protein inhibited the devel-
opment of hematopoiesis and angiogenesis in P-Sp ex-cells to endothelial cells. Some yolk sac cells have been
shown to contain definitive HSCs that can lodge in neo- plant culture, and TIE2-deficient mice showed severely
impaired definitive hematopoiesis. Based on these find-natal liver but not in adult bone marrow (Yoder et al.,
1997a, 1997b). It is interesting to know whether these ings, we conclude that TIE2 is indispensable for the
development of hematopoietic stem cells as well as forHSCs are generated in yolk sac or derived from the OA
and VA. PECAM-11 or TIE21 vascular network formation. On the
other hand, addition of Flk-1-Fc completely abolishedSecond, we established a coculture system of P-Sp
explant at 8.5 d.p.c. with OP9 stromal cells and analyzed the development of endothelial cells and hematopoietic
Role of TIE2 in Definitive Hematopoiesis
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Figure 7. The Effects of Angiopoietin-1 on
Primary TIE21 Cells
(A) The TIE21 cell fraction from the P-Sp ex-
plants of 9.5 d.p.c. embryos, containing part
of the OA and VA, was sorted. The staining
profile obtained with isotype-matched con-
trol IgG is indicated by a dashed line. Data,
given as a percentage, are representative of
three experiments.
(B) Sorted TIE21 cells were promoted to ad-
here to the FN-coated plate by Angiopoietin-1
in a dose-dependent manner. This adhesion
was blocked by saturation of ligands with
TIE2-Fc or by GRGDS peptide. Angiopoietin-2
suppressed this adhesion as a dose-depen-
dent manner. Error bars indicate standard er-
ror of the mean (n 5 3).
(C) Proliferation capacity of hematopoietic
cells was examined in the presence of Angio-
poietin-1 and SCF. Primary TIE21c-Kit1 cells
from OA and VA were cultured on FN-coated
plate in the presence of growth factor(s) for
7 days. (Ca) Cells were not able to survive for
7 days in the absence of factors. (Cb) SCF
(100 ng/ml) promoted cell survival and some
cells adhered to the culture plate (an arrow).
(Cc) Angiopoietin-1 (300 ng/ml) promoted the
cell adhesion to FN and cell morphology
changed (arrows) in the presence of SCF
(100 ng/ml). Moreover, cell proliferation was
significantly increased (see Table 1). (Cd) Addition of Angiopoietin-2 (600 ng/ml) to (Cc) inhibited the cell adhesion to FN and proliferation but
promoted the cell to cell aggregation (an arrow). Scale bar, 33 mm.
cells. This corresponds to the evidence that VEGF re- Angiopoietin-1 and FN on endothelial cells. As the physi-
ologic consequences of the adhesion of TIE21c-Kit1ceptor, Flk-1, was required for the development of both
HSCs and endothelial cells (Shalaby et al., 1997). Flk-1 cells to FN induced by Angiopoietin-1, we found that
hematopoietic proliferation was significantly enhanced.is involved in vasculogenesis, while TIE2 is involved at
the later stages of vascular development or sprouting Angiopoietin-2 suppressed the cell adhesion and prolif-
eration induced by Angiopoietin-1. It is caused by sup-angiogenesis. Corresponding with this, TIE2-deficient
mice showed severely impaired definitive hematopoie- pression of the Angiopoitin-1 signaling (Maisonpierre et
al., 1997). Homophilic aggregation induced by Angio-sis and their P-Sp explants showed abnormalities of
vascular network formation. poietin-2 may be mediated by interaction between inte-
grins and ECM surrounding HSCs. This suggests associ-Third, we show the in vitro function of Angiopoietins
for TIE21 cells. Angiopoietin-1 promoted the adhesion ation of a receptor tyrosine kinase, TIE2, with integrins,
resulting in the cell adhesion. Since MAb against b1to FN and Angiopoietin-2 induced cell±cell adhesion in
TIE2-transfected hematopoietic cells. Thus, the mecha- integrin did not suppress as completely as RGD peptide
did, the involvement of integrins other than b1-familynisms of cell to extracellular matrix (ECM) interaction
(cell adhesion) differ from those of cell to cell interaction such as avb3 and avb5 is likely. And in fact, an associa-
tion of avb3 integrin with the insulin and PDGFb path-(cell aggregation). Cell adhesion is mediated by the inter-
action between integrins on TIE21 HSCs stimulated with ways has been reported (Schneller et al., 1997). Since
Table 1. CFU-C Activity in Primary TIE21c-Kit1 Cells after Stimulation by Angiopoietins and/or SCF
FN Coated Plate Noncoated Plate
Recovered Cells (3103) CFU-C recovered cells (3103) CFU-C
No factor 1.3 6 1.1 0 6 0 0 6 0 0 6 0
Angiopoietin-1 1.3 6 1.1 0 6 0 0 6 0 0 6 0
Angiopoietin-2 0.7 6 1.2 0 6 0 0 6 0 0 6 0
SCF 4.7 6 1.2 26.7 6 5.7 3.0 6 1.7 23.3 6 5.8
SCF1Angiopoietin-1 13.3 6 1.2 303.3 6 9.1 4.0 6 2.0 21.7 6 2.9
SCF1Angiopoietin-11 -2 7.7 6 2.5 33.3 6 5.8 1.3 6 0.6 18.3 6 2.9
Two thousand primary TIE21c-Kit1 cells sorted from OA, VA, and P-Sp of E9.5 murine embryo were cultured on FN-coated or noncoated
culture plate in the presence or absence of different cytokines. The doses applied in this culture were as follows: Angiopoietin-1, 300 ng/ml;
Angiopoietin-2, 600 ng/ml; and SCF, 100 ng/ml. After 7 days of culture, cells were harvested, counted, and transferred to methyl-cellulose
medium containing IL-3, SCF, and Epo. The number of colonies ($ 40 cells) was scored after 7 days of culture. The results represent the
mean 6 SE of triplicate samples.
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Cell Preparation and Flow CytometryTIE2 contains RGD motif in the extracellular domain,
Embryos were staged by somite counting. Dissected embryo andintegrins may bind to TIE2 itself after conformational
yolk sacs were incubated with 0.1% collagenase (Sigma) in 10%change by Angiopoietins. Angiopoietin-1 and 22 is sug-
FCS for 30 min at 378C, and dispersed embryo and yolk sac cells
gested to exist as a trimer or dimer, coupled at the were drawn through a 23G needle. Cultured explants on OP9 cells
coiled-coil domain in the native form (G. D. Y., unpub- were incubated with collagenase as above and harvested by pi-
petting. Debris and aggregated cells were removed through a nylon-lished data). One multimerized Angiopoietin may bind
mesh. The cell-staining procedure for the flow cytometry was asto dimerized TIE2 on the other hematopoietic cells.
described previously (Takakura et al., 1996). The MAbs used inThe HSC adhesion to endothelial cells and aggrega-
immunofluorescence staining were anti-c-Kit (ACK2), anti-TIE2tion were restricted in the OA and VA at 9.0±9.5 d.p.c.
(TEK4), Mac-1 (M1/70), Gr-1 (RB6±8C5), B220 (RA3±6B2), TER119
It is not well understood how the definitive HSCs that (erythroid lineage marker; Ikuta et al., 1990), and anti-CD3 (145±
develop in the P-Sp region proliferate and migrate to 2C11) (Pharmingen). All MAbs were purified and conjugated with
PE or biotin. Biotinylated antibodies were visualized with PE-conju-fetal liver to take part in the embryonal hematopoiesis.
gated streptavidine (GIBCO-BRL) or FITC-conjugated streptavidineb1 integrins have been demonstrated to be required for
(Sigma). The stained cells were analyzed by FACScan or FACSvan-the migration of HSCs to fetal liver by target disruption
tage (Becton Dickinson, San Jose, CA). Sorted TIE21c-Kit1 cellsof this gene (Hirsch et al., 1996).
were suspended in 10% FCS and 1025 M 2ME (Sigma) containing
Our findings strongly support the notion that the de- RPMI1640 (GIBCO-BRL) supplemented with IL-6 (20 ng/ml), IL-7 (20
velopment of HSCs closely involves endothelial cells. ng/ml), SCF (50 ng/ml) and Epo (2 U/ml) at 378C in a humidified 5%-
CO2 air. Cultures were scaled down to 5, 3, 1.5, 0.5, or 0.25 cells inGiven that TIE2 mediates both the adherence of HSCs
0.1 ml for limiting dilution assay.to endothelial cells and the aggregation of HSCs, the
absence of TIE2 leads to a failure of the HSC proliferation
In Vitro Culture of P-Spnormally supported by endothelial cells. Lethal bleeding
The stromal cell line, OP9, was maintained in a-modified minimum
is caused by the decrease of integrity of vascular and essential media (a-MEM, GIBCO-BRL, Gaitherburg, MD) supple-
peri-vascular (smooth muscle) cells. This may be caused mented with 20% fetal calf serum (FCS) (JRH Bioscience, KS) (Na-
by defects of cell±cell interactions mediated by inte- kano et al, 1994). Explants of P-Sp containing a part of the OA of
8.5±9.0 d.p.c. embryos were cultured on OP9 stromal cells in 10%grins. To confirm whether the TIE2 expression on the
FCS and 1025 M 2ME (Sigma, St. Louis, MO) containing RPMI1640vascular cells is required for the hematopoietic stem
(GIBCO-BRL) supplemented with IL-6 (20 ng/ml), IL-7 (20 ng/ml)cells, the contribution of TIE2 double knockout ES cells
(gifts from Dr. T. Sudo, Toray Industries Inc., Kamakura, Japan),
to hematopoiesis should be done. In conclusion, we SCF (50 ng/ml)(a gift from Chemo-Sero-Therapeutic Co., Ltd., Kuma-
demonstrate that the TIE2-Angiopoietin signals play a moto, Japan), and Epo (2 U/ml) (a gift from Snow-Brand Milk Product
critical role in the development of definitive hematopoie- Co, Tochigi, Japan) at 378C in a humidified 5%-CO2 air. The in vitro
colony assay was performed in methylcellulose-containing mediumsis, as well as that of vasculo-angiogenesis.
as described previously (Takakura et al., 1996). In brief, cells disag-
gregated from the culture of P-Sp explants were harvested after 14Experimental Procedures
days, then plated in 1 ml of culture medium containing a-MEM,
1.2% methylcellulose (Aldrich Chemical Co, Milwaukee, WI), 30%Animals
FCS, 1% deionized BSA (Sigma), 50 mM 2-mercaptoethanol, 200C57BL/6 mice were purchased from Japan SLC (Shizuoka, Japan).
U/ml IL-3, 2 U/ml Epo, and 50 ng/ml SCF. On the seventh day ofTIE21/2 mutant mice were maintained in our animal facility for a few
culturing, aggregates consisting of 40 or more cells were countedgenerations. Genotyping of offsprings was performed by Southern
as a single colony.blot analysis as described previously (Dumont et al., 1994).
RT-PCR AnalysisImmunohistochemistry
RNA was extracted at 8.5 d.p.c. from P-Sp region, OP9 cells and atThe procedures for immunohistochemistry of whole embryos and
8 weeks old from ovary using TRIzol (GIBCO-BRL) and was reverse-tissue sections have been described elsewhere (Takakura et al.,
transcribed using a first-strand cDNA synthesis kit (Pharmacia). The1997). An anti-c-Kit antibody (ACK2, rat anti-mouse monoclonal)
cDNAs were amplified with Taq polymerase (Takara, Tokyo, Japan)(Ogawa et al., 1991), an anti-Flk-1 antibody (AVAS12, rat anti-mouse
in a DNA thermocycler (Perkin-Elmer Inc., Norwalk, CT) for 30 to 35monoclonal) (Kataoka et al., 1997) (gifts from Dr. S.-I. Nishikawa,
cycles. Sequences of specific primer for RT-PCR were as follows:Kyoto University, Kyoto, Japan), and an anti-TIE2 antibody (TEK4,
mVEGF (59AGTTCATGGATGTCTACCAGCGAAG/CTCAACCCCAATrat anti-mouse monoclonal) (Yano et al., 1997) were used in this
TTAGCTCCTCCTA 39), mAngiopoietin-1 (59CAGTGGCTGCAAAAACassay. In brief, the primary antibody was developed with horseradish
TTGA/TCTGCACAGTCTCGAAATGG39), mAngiopoietin-2 (59CACACperoxidase-conjugated anti-rat Ig antibody (Biosource; Camarillo,
TGACCTTCCCCAACT/TGGTGTCTCTCAGTGCCTTG39), and mb-actinCA). In the final step of staining, samples were soaked with PBS
(59TCGTGCGTGACATCAAAGAG/TGGACAGTGAGGCCAGGATG39).containing 250 mg/ml diaminobenzidine (Dojin Chem.; Kumamoto,
Each cycle consisted of 30 sec denaturation at 948C, 2 min annealingJapan) in the presence or absence of 0.05% NiCl2 for 10±30 min, and
at 648C, and 2 min extension at 728C.hydrogen peroxide was added to 0.01% for the enzymatic reaction.
An anti-PECAM-1 antibody (MEC13.3, rat anti-mouse monoclonal;
Production of Recombinant Fusion ProteinPharmingen, San Diego, CA), ACK2, and TEK4 were used for staining
Recombinant fusion proteins of the extracellular domain of murineof the cultured cells on 12-well culture plates. After plating, the cells
surface molecules and the Fc part of human Ig were designed. TIE-were fixed with 4% paraformaldehyde in PBS for 10 min at room
2-Fc, Flk-1-Fc, and CD4-Fc were produced by COS7 cells in serum-temperature. Biotinylated ACK2 was developed with alkaline phos-
free conditioned medium as previously described (Yano et al., 1997)phatase (ALP) conjugated streptavidin (DAKO; Glostrup, Denmark).
and purified over protein-A columns (Prosep-A, Bioprocessing,New fuchsin (DAKO) was used for the color reaction.
Princeton, NJ). Their purity and disulfide-linked dimerization wereFor the detection of embryonic or adult hemoglobin, rabbit anti-
assessed by Coomassie Brilliant Blue staining of SDS gels.embryonic (a gift from Dr. T. Atsumi, Tsukuba Life Science Center,
Ibaraki, Japan) (Miwa et al., 1991) or anti-adult (Cappel, Durham,
NC) hemoglobin polyclonal antibody, respectively, was used. The Adhesion and Aggregation of TIE21 Cells in Culture
Murine pro-B cell line, Ba/F3 (Palacios and Steinmetz, 1985), wasprimary antibody was developed with biotinylated anti-rabbit Ig anti-
body (Biosource), and subsequently, ALP-conjugated streptavidin cultured in 0.1% BSA containing SA, serum-free media (Chemo-
Sero-Therapeutic Co., Ltd.) supplemented with 100 U/ml IL-3. Stable(DAKO). Then, new fuchsin was used for the color reaction.
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transformant BaF/TIE2 cells were established by transfection of full- maturation potential occurs at the level of hematopoietic stem cells.
Cell 62, 863±874.length murine TIE2 (Yano et al., 1997). Primary TIE21 cells were
sorted by FACSvantage (Becton). In brief, P-Sp explants containing Iwama, A., Hamaguchi, I., Hashiyama, M., Murayama, Y., Yasunaga,
part of the OA and VA were dissected from 9.5 d.p.c. murine em- K., and Suda, T. (1993). Molecular cloning and characterization of
bryos. The tissue was dissociated by incubation with 2.4 U/ml dis- mouse TIE and TEK receptor tyrosine kinase genes and their expres-
pase (Boehringer; Mannheim, Germany) for 10 min at room tempera- sion in hematopoietic stem cells. Biochem. Biophys. Res. Comm.
ture and subsequent drawing through a 23G needle. Debris and cell 195, 301±309.
aggregations were removed with a nylon-mesh. Single cells from Johnson, G.R., and Moore, M.A.S. (1975). Role of stem cell migration
tissue were stained with biotinylated TEK4 detected by streptavi- in initiation of mouse foetal liver hematopoiesis. Nature 258,
din-PE. 726±728.
BaF/TIE2 cells (5 3 105) and primary TIE21 cells (104) were incu-
Kataoka, H., Takakura, N., Nishikawa, S., Tsuchida, K., Kodama,bated in the presence or absence of human recombinant Angiopoie-
H., Kunisada, T., Risau, W., Kita, T., and Nishikawa, S.-I. (1997).tin-1 (50±300 ng/ml) or Angiopoietin-2 (100±600 ng/ml) with or with-
Expression of PDGF receptor alpha, c-Kit and Flk-1 genes clustering
out TIE2-Fc (100-fold molecular weight of Angiopoietin-1), GRGDS,
in mouse chromosome 5 define distinct subsets of nascent meso-
GRGES (both 0.5 mg/ml, American Peptide Co., CA) blocking mono-
dermal cells. Develop. Growth Differ. 39, 729±740.
clonal antibody against b1 integrin (10 mg/ml) (KM16, a gift from Dr.
Maisonpierre, P.C., Suri, C., Jones, P.F., Bartunkova, S., Wiegand,Miyake, Saga Univ., Saga, Japan) (Wu et al., 1994), and control
S.J., Radziejewski, C., Compton, D., McClain, J., Aldrich, T.H., Papa-purified rat IgG (10 mg/ml) for 30 min at 378C. Cells incubated as
dopoulos, N., et al. (1997). Angiopoietin-2, a natural antagonist forabove were cultured on human FN-coated (coated for 1 hr at 10
Tie2 that disrupts in vivo angiogenesis. Science 277, 55±61.mg/ml, IWAKI glass, Chiba, Japan) and noncoated tissue culture
Medvinsky, A., and Dierzak, E. (1996). Definitive hematopoiesis isplate for 30 min to 24 hr at 378C. Before applying the cell to the
autonomously initiated by the AGM region. Cell 86, 897±906.plate, both FN-coated and noncoated plate were preincubated with
2% BSA in PBS prior to receiving cells. For the evaluation of adher- Medvinsky, A.L., Samoylina, N.L., MuÈ ller, A.M., and Dzierzak, E.A.
ence to FN, floating cells were harvested by gentle pipetting after (1993). An early pre-liver intra-embryonic source of CFU-S in the
culturing for 30 min, and then counted under microscope. Specific developing mouse. Nature 364, 64±66.
binding to FN was evaluated by subtracting the ratio of adherent Miwa, Y., Atsumi, T., Imai, N., and Ikawa. Y. (1991). Primitive erythro-
cells on noncoated plate from that on FN-coated plates. To assay poiesis of mouse teratocarcinoma stem cells PCC3/A/1 in serum-
for aggregation of BaF/TIE2 cells, cells were treated as above, cul- free medium. Development 111, 543±549.
tured for 24 hr, and then evaluated under a microscope for aggre-
MuÈ ller, A.M., Medvinsky, A., Strouboulis, J., Grosveld, F., and Dzier-
gation.
zak, E. (1994). Development of hematopoietic stem cell activity in
the mouse embryo. Immunity 1, 291±301.
Acknowledgments Nakano, T., Kodama, H., and Honjo, T. (1994). Generation of lympho-
hematopoietic cells from embryonic stem cells in culture. Science
This work was supported by Grants-in-Aid for Scientific Research on 265, 1098±1101.
Priority Areas from the Ministry of Education, Science, and Culture of
Ogawa, M., Matsuzaki, Y., Nishikawa, S., Hayashi, S.I., Kunisada,Japan. The authors thank Hiroaki Kodama for providing us with OP9
T., Sudo, T., Kina, T., Nakauchi, H., and Nishikawa. S.-I. (1991).stromal cells.
Expression and function of c-kit in hemopoietic progenitor cells. J.
Exp. Med. 174, 63±71.
Received May 6, 1998; revised October 13, 1998.
Palacios, R., and Steinmetz, M. (1985). IL-3-dependent mouse
clones that express B-220 surface antigen, contain Ig genes in germ-
References line configuration, and generate B lymphocytes in vivo. Cell 41,
727±734.
Cumano, A., Diterien-Lievre, F., and Godin, I. (1996). Lymphoid po- Partanen, J., Armstrong, E., Makela, T.P., Korhonen, J., Sandberg,
tential, probed before circulation in mouse, is restricted to caudal M., Renkonen, R., Knuutila, S., Huebner, K., and Alitalo, K. (1992).
intraembryonic splanchnopleura. Cell 86, 907±916. A novel endothelial cell surface receptor tyrosine kinase with extra-
Davis, S., Aldrich, T.H., Jones, P.F., Acheson, A., Compton, D.L., cellular epidermal growth factor homology domains. Mol. Cell. Biol.
Jain, V., Ryan, T.E., Bruno, J., Radziejewski, C., Maisonpierre, P.C., 12, 1698±1707.
et al. (1996). Isolation of angiopoietin-1, a ligand for the TIE2 recep- Puri, M.C., Rossant, J., Alitalo, K., Bernstein, A., and Partanen, J.
tor, by secretion-trap expression cloning. Cell 87, 1161±1169. (1995). The receptor tyrosine kinase TIE is required for integrity and
Dumont, D.J., Yamaguchi, T.P., Conlon, R.A., Rossant, J., and Breit- survival of vascular endothelial cells. EMBO J. 14, 5884±5891.
man, M.L. (1992). tek, a novel tyrosine kinase gene located on mouse Sato, T.N., Tozawa, Y., Deutsch, U., Wolburg-Buchholz, K., Fujiwara,
chromosome 4, is expressed in endothelial cells and their presump- Y., Gendron-Maguire, M., Gridley, T., Wolburg, H., Risau, W., and
tive precursors. Oncogene 7, 1471±1480. Qin, Y. (1995). Distinct roles of the receptor tyrosine kinases Tie-1
Dumont, D.J., Gradwohl, G.J., Fong, G.-H., Puri, M.C., Gertsenstein, and Tie-2 in blood vessel formation. Nature 376, 70±74.
M., Auerbach, A., and Breitman, M.L. (1994). Dominant-negative and Schneller, M., Vuori, K., and Rouslahti, E. (1997). aVb3 integrin asso-
targeted null mutations in the endothelial receptor tyrosine kinase, ciates with activated insulin and PDGFb receptors and potentiates
tek, reveal a critical role in vasculogenesis of embryo. Genes Dev. the biological activity of PDGF. EMBO J. 16, 5600±5607.
8, 1897±1909.
Shalaby, F., Rossant. J., Yamaguchi. T.P., Gertsenstein, M., Wu,
Eichmann, A., Corbel, C., Nataf, V., Vaigot, P., Breant, C., and Le X.-F., Breitman, M.L., and Schuh, A.C. (1995). Failure of blood-island
Douarin, N.M. (1997). Ligand-dependent development of the endo- formation and vasculogenesis in Flk-1-deficient mice. Nature 376,
thelial and hemopoietic lineages from embryonic mesodermal cells 62±74.
expressing vascular endothelial growth factor receptor 2. Proc. Natl. Shalaby, F., Ho, J., Stanford, W.L., Fischer, K.-L., Schuh, A.C.,
Acad. Sci. USA 94, 5141±5146. Schwarz, L., Bernstein, A., and Rossant, J. (1997). A requirement
Fong, G-H., Rossant, J., Gertsenstein, M., and Breitman, M.L. (1995). for Flk1 in primitive and definitive hematopoiesis and vasculogen-
Role of the Flt-1 receptor tyrosine kinase in regulating the assembly esis. Cell 89, 981±990.
of vascular endothelium. Nature 376, 66±70. Suri, C., Jones, P.F., Patan, S., Bartunkova, S., Maisonpierre, P.C.,
Hirsch, E., Iglesias, A., Potocnik, A.J., Hartmann, U., and FaÈ ssler, R. Davis, S., Sato, T.N., and Yancopoulos, G.D. (1996). Requisite role
(1996). Impaired migration but not differentiation of haematopoietic of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic
stem cells in the absence of b1 integrins. Nature 380, 171±175. angiogenesis. Cell 87, 1171±1180.
Ikuta, K., Kina, T., MacNeil, I., Uchida, N., Peault, B., Chein, Y.H., and Takakura, N., Kodama, H., Nishikawa, S., and Nishikawa, S.-I. (1996).
Preferential proliferation of murine colony-forming units in cultureWeissman, I.L. (1990). A developmental switch in thymic lymphocyte
Immunity
686
in a chemically defined condition with a macrophage colony-stimu-
lating factor-negative stromal cell clone. J. Exp. Med. 184, 2301±
2309.
Takakura, N., Yoshida, H., Ogura, Y., Kataoka, H., Nishikawa, S.,
and Nishikawa, S.-I. (1997). PDGFRa expression during mouse em-
bryogenesis: immunolocalization analyzed by whole-mount immu-
nohistostaining using the monoclonal anti-mouse PDGFRa antibody
APA5. J. Histochem. Cytochem. 45, 883±893.
Vikkula, M., Boon, L.M., Carraway, K.L., III, Calvert, J.T., Diamonti,
A.J., Goumnerov, B., Pasysk, K.A., Marchuk, D.A., Warman, M.L.,
Cantly, L.C., et al. (1996). Vascular dysmorphogenesis caused by
an activating mutation in the receptor tyrosine kinase TIE2. Cell 87,
1181±1190.
Wood, H.B., Gay, G., Healy, L., Enver, T., and Morris-Kay, G.M.
(1997). CD34 expression patterns during early mouse development
are related to modes of blood vessel formation and reveal additional
sites of hematopoiesis. Blood 90, 2300±2311.
Wu, X., Miyake, K., Medina, K.L., Kincade, P.W., and Gimble, J.M.
(1994). Recognition of murine integrin b1 by a rat anti-stromal cell
monoclonal antibody. Hybridoma 13, 409±416.
Yano, M., Iwama, A., Nishio, H., Suda, J., Takada, G., and Suda, T.
(1997). Expression and function of murine receptor tyrosine kinases,
TIE and TEK, in hematopoietic stem cells. Blood 89, 4317±4326.
Yoder, M.C., Hiatt, K., Dutt, P., Mukherjee, P., Bodine, D.M., and
Orlic, D. (1997a). Characterization of definitive lymphohematopoietic
stem cells in the day 9 murine yolk sac. Immunity 7, 335±344.
Yoder, M.C., Hiatt, K., and Mukherjee, P. (1997b). In vitro repopulat-
ing hematopoietic stem cells are present in the murine yolk sac at
day 9.0 postcoitus. Proc. Natl. Acad. Sci. USA 94, 6776±6780.
